Literature DB >> 15123058

Menorrhagia and abnormal bleeding before the menopause.

Steven R Goldstein1.   

Abstract

Abnormal uterine bleeding before the menopause accounts for 20% of visits to the gynaecology clinic and almost 25% of gynaecological operations. The patient who presents with such bleeding presents two distinct but important challenges for the clinician. The first is the exclusion of cancer or hyperplasia; the second is dealing with the annoyance as well as the fear that the bleeding engenders in the patient. Any attempt at appropriate therapy--whether surgical, hormonal or expectant--begins with an accurate diagnosis. Transvaginal ultrasound with saline infusion sonohysterography for selective patients has emerged as a safe, non-invasive and, inexpensive method of triaging patients with abnormal uterine bleeding in order to determine which patients require no further evaluation, blind endometrial sampling for a global endometrial process or visually directed endometrial sampling when pathology is thought to be focal.

Entities:  

Mesh:

Year:  2004        PMID: 15123058     DOI: 10.1016/j.bpobgyn.2003.10.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  3 in total

1.  Menorrhagia: a synopsis of management focusing on herbal and nutritional supplements, and chiropractic.

Authors:  Anna B Livdans-Forret; Phyllis J Harvey; Susan M Larkin-Thier
Journal:  J Can Chiropr Assoc       Date:  2007-12

2.  A Comparative Observational Study of the Use of Saline Uterine Hydrosonography for the Diagnosis and Assessment of Uterine Cavity Lesions in Women.

Authors:  Veluppillai Vathanan; Nii Adjeidu Armar
Journal:  Int J Reprod Med       Date:  2016-08-11

3.  A network pharmacology-based strategy deciphers the underlying molecular mechanisms of Qixuehe Capsule in the treatment of menstrual disorders.

Authors:  Yanqiong Zhang; Xia Mao; Jing Su; Ya Geng; Rui Guo; Shihuan Tang; Junfang Li; Xuefeng Xiao; Haiyu Xu; Hongjun Yang
Journal:  Chin Med       Date:  2017-08-21       Impact factor: 5.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.